Cargando…

Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells

Tumor cells overexpress low-density lipoprotein (LDL) receptors (LDL-r). Hence, LDL is proposed as a targeting shuttle of anticancer drugs. Therefore, the objective of this study was to synthesize a dual inhibitor of heat shock protein 27 (HSP27) and human epidermal growth factor receptor 2 (HER2) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhadad, Laila J., Harisa, Gamaleldin I., Alanazi, Fars K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132616/ https://www.ncbi.nlm.nih.gov/pubmed/32273796 http://dx.doi.org/10.1016/j.jsps.2020.01.020

Ejemplares similares

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs
por: Harisa, Gamaleldin I., et al.
Publicado: (2013)

Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors
por: Jaragh-Alhadad, Laila, et al.
Publicado: (2022)

The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study
por: Harisa, Gamaleldin I., et al.
Publicado: (2015)

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition
por: Alanazi, Saleh A., et al.
Publicado: (2021)

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons
por: Harisa, Gamaleldin I., et al.
Publicado: (2023)

Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers
por: Jaragh-Alhadad, Laila, et al.
Publicado: (2022)

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
por: Sherif, Abdelrahman Y., et al.
Publicado: (2022)

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
por: Sherif, Abdelrahman Y, et al.
Publicado: (2022)

Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer
por: Sherif, Abdelrahman Y., et al.
Publicado: (2023)

Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
por: Faris, Tarek M., et al.
Publicado: (2020)

Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer
por: Harisa, Gamaleldin I., et al.
Publicado: (2016)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Chitosan-Coated Flexible Liposomes Magnify the Anticancer Activity and Bioavailability of Docetaxel: Impact on Composition
por: Alshraim, Mohammed O., et al.
Publicado: (2019)

Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2022)

Expressions of HSP70 and HSP27 in Hepatocellular Carcinoma
por: Joo, Mee, et al.
Publicado: (2005)

Hsp27 and Hsp70 Expression in Esophageal Squamous
por: Luz, Caio Cesar Floriano, et al.
Publicado: (2017)

Hsp27-Actin Interaction
por: Graceffa, Philip
Publicado: (2011)

Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules
por: Kim, Jee Hye, et al.
Publicado: (2016)

Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
por: Hwang, Soo-Yeon, et al.
Publicado: (2020)

Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo
por: Li, Junyang, et al.
Publicado: (2016)

Serum high-density lipoprotein level and prognosis of ovarian cancer
por: Hongyan, Jiang, et al.
Publicado: (2023)

The Role of Hsp27 in Chemotherapy Resistance
por: Lampros, Marios, et al.
Publicado: (2022)

Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
por: Kang, Se Hun, et al.
Publicado: (2008)

Phosphorylation of Ser(78 )of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer
por: Zhang, Daohai, et al.
Publicado: (2007)

HSP27 inhibitor attenuates radiation-induced pulmonary inflammation
por: Kim, Jee-Youn, et al.
Publicado: (2018)

MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27
por: Pai, Hui Chen, et al.
Publicado: (2015)

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016)

HSP27 phosphorylation inhibitor regulates Her2 expression in human breast cancer cell line SK-BR-3 with induced Herceptin resistance
por: Kim, Min Kyung, et al.
Publicado: (2014)

HSP27 and HSP70 expression in squamous cell carcinoma: An immunohistochemical study
por: Deyhimi, Parviz, et al.
Publicado: (2012)

Encapsulation of chloroquine and doxorubicin by MPEG-PLA to enhance anticancer effects by lysosomes inhibition in ovarian cancer
por: Shao, Ming, et al.
Publicado: (2018)

Pravastatin Provides Antioxidant Activity and Protection Of Erythrocytes Loaded Primaquine
por: Alanazi, Fars
Publicado: (2010)

Heat Shock Protein HSP27 Secretion by Ovarian Cancer Cells Is Linked to Intracellular Expression Levels, Occurs Independently of the Endoplasmic Reticulum Pathway and HSP27's Phosphorylation Status, and Is Mediated by Exosome Liberation
por: Stope, Matthias B., et al.
Publicado: (2017)

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets
por: Katsogiannou, Maria, et al.
Publicado: (2014)

Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications
por: Ardestani, Mina, et al.
Publicado: (2022)

The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90
por: Alberti, Giusi, et al.
Publicado: (2022)

HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy
por: Lin, Tzu-yin, et al.
Publicado: (2016)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target
por: Vidyasagar, Aparna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3v87i19r0nug3qd04toss93d1u